Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8‑K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 20, 2019 CHEMED CORPORATION (Exact name of registrant as specified in its charter) Delaware                         1‑8351                          31‑0791746 (State or other           (Commission File Number)    (I.R.S. Employer jurisdiction of                                                             Identification incorporation)                                                                  Number) 2600 First Financial Center, 255 East 5th Street, Cincinnati, OH 45202 (Address of principal executive offices)             (Zip Code) Registrant's telephone number, including area code: (513) 762‑6690 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below): [_]     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [_]     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12) [_]     Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b)) [_]     Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c)) Securities registered pursuant to 12(b) of the Act:   Title of each class   Trading symbol Name of each exchange on which registered Capital stock $1 par value CHE New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.  [_] If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [_] Page 1 of 3 Item 5.07           Submission of Matters to a Vote of Security Holders (a)              On May 20, 2019, Chemed Corporation held its annual meeting of stockholders. (b)      Stockholders voted on the matters set forth below: Item 1.  Election of Directors.   The following directors, who constitute the entire Board of Directors, were elected at the meeting by the votes indicated:   Nominee     For     Against     Abstentions   Broker non- votes Kevin J. McNamara   12,984,787   123,443   19,461   1,123,485 George J. Walsh III   10,636,933   2,463,422   27,336   1,123,485 Joel F. Gemunder   10,553,403   2,545,065   29,223   1,123,485 Patrick P. Grace   10,186,087   2,817,212   124,392   1,123,485 Thomas C. Hutton   12,732,063   377,111   18,517   1,123,485 Walter L. Krebs   12,442,399   660,028   25,264   1,123,485 Andrea R. Lindell   12,959,153   143,278   25,260   1,123,485 Thomas P. Rice   13,005,644   88,741   33,306   1,123,485 Donald E. Saunders   12,431,985   668,004   27,702   1,123,485 Frank E. Wood   12,439,547   661,985   26,159   1,123,485 Item 2.  Ratification of Independent Accountants.   The proposal to ratify the appointment of PricewaterhouseCoopers LLP by the Audit Committee of the Board of Directors as the company’s independent accountants for the year ending December 31, 2019, was approved with the following votes:     Voted   For   13,662,992     Against        543,626     Abstain          44,558     Item 3.  Executive Compensation.   The proposal to approve, on a non-binding basis, the Company’s executive compensation program, was approved with the following votes:     Voted   For   12,528,451     Against   562,767     Abstain   36,473     Broker non-votes   1,123,485     Page 2 of 3 Item 4.  Stockholder Proposal.   The stockholder proposal requesting a semi-annual report on (a) the Company’s policies on political spending and (b) political contributions made was disapproved with the following votes     Voted   For   6,025,781     Against   7,016,935     Abstain   84,975     Broker non-votes   1,123,485     SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.       CHEMED CORPORATION               Dated: May 22, 2019   By: /s/ Michael D. Witzeman           Michael D. Witzeman           Vice President and Controller   Page 3 of 3